Mobile Medically Supervised Patient Management in Rheumatoid Arthritis
MiDEAR
1 other identifier
observational
60
1 country
1
Brief Summary
The purpose of this study is to evaluate the use, usability and feasibility of an Application (App) for patients with rheumatoid arthritis with diary functionalities, in patient-physician interaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 16, 2015
CompletedFirst Posted
Study publicly available on registry
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedSeptember 26, 2023
September 1, 2023
1.7 years
September 16, 2015
September 25, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of use of the RheumaLive Application in patients with rheumatoid arthritis.
Evaluation of use by counting and by a patient paper-based questionnaire
baseline and change over up to nine months
Secondary Outcomes (3)
Comparison paper-based vs electronic PROM in the App - Differences of the scores
baseline and change after 3 months
Evaluation of feasibility of the RheumaLive Application in patients with rheumatoid arthritis.
at 3 months from start and change over 6 more months
Evaluation of usability of the RheumaLive Application in patients with rheumatoid arthritis.
at 3 months from start and change over 6 more months
Study Arms (2)
RheumaLive App use
RheumaLive App use and evaluation of feasibility
RheumaLive App use & threshold values
RheumaLive App use and evaluation of feasibility
Interventions
Eligibility Criteria
RA patients
You may qualify if:
- age \>= 18 years, owner of App capable device, RA, informed consent
You may not qualify if:
- non German speaking, no App capable device available
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Policlinic for Rheumatology & Hiller Research Centre for Rheumatology
Düsseldorf, 40225, Germany
Related Publications (1)
Richter JG, Nannen C, Chehab G, Acar H, Becker A, Willers R, Huscher D, Schneider M. Mobile App-based documentation of patient-reported outcomes - 3-months results from a proof-of-concept study on modern rheumatology patient management. Arthritis Res Ther. 2021 Apr 19;23(1):121. doi: 10.1186/s13075-021-02500-3.
PMID: 33874994DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias Schneider, Prof.
Heinrich-Heine University, Duesseldorf
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2015
First Posted
October 1, 2015
Study Start
November 1, 2014
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
September 26, 2023
Record last verified: 2023-09